102 related articles for article (PubMed ID: 30779920)
1. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.
Naderi A
Exp Cell Res; 2019 Mar; 376(2):221-226. PubMed ID: 30779920
[TBL] [Abstract][Full Text] [Related]
2. BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Naderi A; Liu J; Hughes-Davies L
Mol Cancer; 2010 May; 9():111. PubMed ID: 20482821
[TBL] [Abstract][Full Text] [Related]
3. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Naderi A; Liu J; Francis GD
Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
[TBL] [Abstract][Full Text] [Related]
4. BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
Naderi A; Liu J; Bennett IC
Int J Cancer; 2010 Apr; 126(7):1596-610. PubMed ID: 19711341
[TBL] [Abstract][Full Text] [Related]
5. BEX2 promotes tumor proliferation in colorectal cancer.
Hu Y; Xiao Q; Chen H; He J; Tan Y; Liu Y; Wang Z; Yang Q; Shen X; Huang Y; Yuan Y; Ding K
Int J Biol Sci; 2017; 13(3):286-294. PubMed ID: 28367093
[TBL] [Abstract][Full Text] [Related]
6. Bex2 regulates cell proliferation and apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway.
Zhou X; Meng Q; Xu X; Zhi T; Shi Q; Wang Y; Yu R
Biochem Biophys Res Commun; 2012 Oct; 427(3):574-80. PubMed ID: 23022184
[TBL] [Abstract][Full Text] [Related]
7. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.
Naderi A; Teschendorff AE; Beigel J; Cariati M; Ellis IO; Brenton JD; Caldas C
Cancer Res; 2007 Jul; 67(14):6725-36. PubMed ID: 17638883
[TBL] [Abstract][Full Text] [Related]
8. Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway.
Meng Q; Zhi T; Chao Y; Nie E; Xu X; Shi Q; Hua L; Wang L; Zhan W; Wang Y; Zhou X; Yu R
J Mol Neurosci; 2014 Jun; 53(2):262-70. PubMed ID: 24390962
[TBL] [Abstract][Full Text] [Related]
9. Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis.
Hu Z; Wang Y; Huang F; Chen R; Li C; Wang F; Goto J; Kwiatkowski DJ; Wdzieczak-Bakala J; Tu P; Liu J; Zha X; Zhang H
J Biol Chem; 2015 Oct; 290(42):25756-65. PubMed ID: 26296882
[TBL] [Abstract][Full Text] [Related]
10. Β-catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition.
Nie E; Zhang X; Xie S; Shi Q; Hu J; Meng Q; Zhou X; Yu R
Biochem Biophys Res Commun; 2015 Jan; 456(1):494-9. PubMed ID: 25490384
[TBL] [Abstract][Full Text] [Related]
11. Silencing of brain-expressed X-linked 2 (BEX2) promotes colorectal cancer metastasis through the Hedgehog signaling pathway.
Tan Y; Hu Y; Xiao Q; Tang Y; Chen H; He J; Chen L; Jiang K; Wang Z; Yuan Y; Ding K
Int J Biol Sci; 2020; 16(2):228-238. PubMed ID: 31929751
[TBL] [Abstract][Full Text] [Related]
12. Bex2 is critical for migration and invasion in malignant glioma cells.
Zhou X; Xu X; Meng Q; Hu J; Zhi T; Shi Q; Yu R
J Mol Neurosci; 2013 May; 50(1):78-87. PubMed ID: 22907646
[TBL] [Abstract][Full Text] [Related]
13. Brain-Expressed X-linked (BEX) proteins in human cancers.
Kazi JU; Kabir NN; Rönnstrand L
Biochim Biophys Acta; 2015 Dec; 1856(2):226-33. PubMed ID: 26408910
[TBL] [Abstract][Full Text] [Related]
14. JNK/MAPK pathway regulation by BEX2 gene silencing in alcoholic hepatitis mice: Effects on oxidative stress.
Zhou S; Zhong H; Wang Y; Wang X; Pan H; Liu X; Hu L
Alcohol Clin Exp Res (Hoboken); 2023 Oct; 47(10):1869-1882. PubMed ID: 37864534
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
16. BEX2 is poor prognostic factor and required for cancer stemness in gastric cancer.
Yasumoto A; Fujimori H; Mochizuki M; Shibuya-Takahashi R; Nakamura-Shima M; Shindo N; Yamaguchi K; Fukushi D; Wakui Y; Sugai T; Iwai W; Abue M; Sato I; Satoh K; Katayose Y; Yasuda J; Shibata C; Tamai K
Biochem Biophys Res Commun; 2023 May; 655():59-67. PubMed ID: 36933308
[TBL] [Abstract][Full Text] [Related]
17. Crotonylated BEX2 interacts with NDP52 and enhances mitophagy to modulate chemotherapeutic agent-induced apoptosis in non-small-cell lung cancer cells.
Mu N; Wang Y; Li X; Du Z; Wu Y; Su M; Wang Y; Sun X; Su L; Liu X
Cell Death Dis; 2023 Sep; 14(9):645. PubMed ID: 37777549
[TBL] [Abstract][Full Text] [Related]
18. Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression.
Le Mercier M; Fortin S; Mathieu V; Roland I; Spiegl-Kreinecker S; Haibe-Kains B; Bontempi G; Decaestecker C; Berger W; Lefranc F; Kiss R
Neoplasia; 2009 May; 11(5):485-96. PubMed ID: 19412433
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
20. Up-Regulation of Glioma-Associated Oncogene Homolog 1 Expression by Serum Starvation Promotes Cell Survival in ER-Positive Breast Cancer Cells.
Xu J; Huang G; Zhang Z; Zhao J; Zhang M; Wang Y; Liu Z; Lu J
Cell Physiol Biochem; 2015; 36(5):1862-76. PubMed ID: 26182949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
